Denali Therapeutics

Denali Therapeutics

Biotechnology Research South San Francisco, California, United States 549 employees
Employees
549
Contacts
4
Emails
4
Phones
2

Denali Therapeutics Overview

Headquarters
South San Francisco, California, United States
Industry
Biotechnology Research
Employees
549
Founded
2015
Funding
500.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Denali Therapeutics

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families. Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development. Our team thrives in a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Our ability to have a positive impact on people’s lives is directly related to the trust we have in each other and our ability to unify our diverse backgrounds and experience behind our purpose to defeat degeneration.

Denali Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Denali Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Pam Litten Senior Manager Hris, Workday
Email Phone
Steve Krognes
Email Phone
Sophie Wallace
Email
Kristi Griffin Director, Human Resources at Denali Therapeutics
Email

Employees by Management Level

Manager 17 profiles
Director 15 profiles
Individual contributor 12 profiles
Senior / Lead 4 profiles
Associate / junior 2 profiles
Executive 1 profile

Department Contact Coverage

Department Contacts Email Phone
IT 7 7 3
General 6 6 2
Operations 4 4 3
Executive 4 4 2
Healthcare 4 4 1
Legal 2 2 1

Denali Therapeutics Tech Stack

Data / AI 8 profiles
Engineering 5 profiles

Compare Similar Companies to Denali Therapeutics